Slow-wave sleep and daytime functioning in chronic fatigue syndrome: effects of sodium oxybate
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2016
Price : $35 *
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Chronic fatigue syndrome
- Focus Therapeutic Use
- Acronyms SAFFE
- 31 Aug 2018 Biomarkers information updated
- 26 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2015 Accrual to date is 241 % according to United Kingdom Clinical Research Network record.